FDA cleared the Axial3D Insight from Axial Medical Printing Limited on Sep 18, 2025 under K250369, a traditional 510(k). The device falls under product code QIH, Automated Radiological Image Processing Software, regulated at 21 CFR 892.2050 as a Class 2 device. The review panel was Radiology.
FDA logged the submission as received on Feb 10, 2025. The decision came 220 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Axial Medical Printing Limited in the last 12 months of the tracker.